Henry Schein (NASDAQ:HSIC) Share Price Breaks Below Fifty Day Moving Average - Here's What Happened

Henry Schein logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Henry Schein shares fell below their 50-day moving average of $85.81, trading as low as $83.87 and last at $84.96.
  • Analysts have a consensus “Moderate Buy” rating and an average price target of $93.57; eight rate the stock Buy, five Hold, and one Sell.
  • Quarterly EPS of $1.56 beat the $1.36 consensus, while revenue of $3.47 billion was slightly below estimates but increased 4% year over year.
  • Interested in Henry Schein? Here are five stocks we like better.

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $85.81 and traded as low as $83.87. Henry Schein shares last traded at $84.96, with a volume of 1,711,282 shares.

Analyst Upgrades and Downgrades

HSIC has been the subject of several research reports. Leerink Partners set a $92.00 price target on shares of Henry Schein and gave the stock a "market perform" rating in a research note on Wednesday, October 14th. Citigroup reissued a "buy" rating and issued a $112.00 price objective (up from $100.00) on shares of Henry Schein in a research report on Wednesday, August 5th. BTIG Research increased their target price on shares of Henry Schein from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Wednesday, August 19th. Barrington Research set a $104.00 target price on shares of Henry Schein in a research report on Wednesday, August 5th. Finally, Piper Sandler lifted their price target on shares of Henry Schein from $91.00 to $95.00 and gave the company an "overweight" rating in a research note on Wednesday, July 29th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and a consensus target price of $93.57.

View Our Latest Report on HSIC

Henry Schein Stock Performance

The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.76 and a current ratio of 1.33. The stock's fifty day moving average price is $85.81 and its 200-day moving average price is $81.59. The company has a market capitalization of $9.39 billion, a P/E ratio of 23.28, a PEG ratio of 1.51 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.20. Henry Schein had a net margin of 3.07% and a return on equity of 16.39%. The business had revenue of $3.47 billion during the quarter, compared to the consensus estimate of $3.48 billion. During the same period last year, the business posted $1.38 EPS. Henry Schein's revenue was up 4.0% on a year-over-year basis. As a group, research analysts anticipate that Henry Schein, Inc. will post 5.55 EPS for the current fiscal year.

Institutional Trading of Henry Schein

Institutional investors and hedge funds have recently bought and sold shares of the business. Southpoint Capital Advisors LP lifted its position in shares of Henry Schein by 28.0% in the first quarter. Southpoint Capital Advisors LP now owns 3,200,000 shares of the company's stock valued at $235,840,000 after buying an additional 700,000 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Henry Schein by 2.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,873,004 shares of the company's stock worth $211,734,000 after acquiring an additional 56,687 shares during the period. M.D. Sass LLC increased its holdings in shares of Henry Schein by 2.9% during the 1st quarter. M.D. Sass LLC now owns 1,273,316 shares of the company's stock worth $93,843,000 after acquiring an additional 35,443 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Henry Schein by 5.9% during the 1st quarter. Bank of America Corp DE now owns 1,221,585 shares of the company's stock worth $90,031,000 after acquiring an additional 68,593 shares during the last quarter. Finally, Defilade Capital Management L.P. increased its holdings in shares of Henry Schein by 94.8% during the 1st quarter. Defilade Capital Management L.P. now owns 624,037 shares of the company's stock worth $45,992,000 after acquiring an additional 303,615 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc. is a global distributor of health care products and services, serving dental and medical practitioners, veterinary professionals, and other health care organizations. The company traces its roots to a pharmacy founded by Henry and Esther Schein in Queens, New York, in 1932. Its offerings include medical and dental supplies, equipment, pharmaceuticals, vaccines, and diagnostic products. Henry Schein also provides practice-management software, technology solutions, and business services designed to help health care professionals manage their operations.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines